CYTOVAC A/S: Financial statements 2019
CVR: 31262666
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -34,142,000 compared with DKK -30,352,000 the year before. Equity in the 2019 report amounted to DKK -37,935,000.
- Profit/Loss
- DKK -34,142,000
- Equity
- DKK -37,935,000
- Total Assets
- DKK 7,504,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -34.1M | -37.9M | - |
| 2018 | - | - | -30.4M | -3.8M | - |
| 2017 | - | -11.5M | -14.9M | 3.5M | 14 |
| 2016 | - | -9.1M | -12.7M | 9.3M | 12 |
| 2015 | - | -9.2M | -12.2M | 5.9M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CYTOVAC A/S has published its annual report for 2018. The net result was DKK -30,352,000.
As of April 15, 2019, Frederik Franz Johan Wilhelm Buch has joined the board of directors of CYTOVAC A/S.
As of April 15, 2019, Lars-Christian Brask has left the board of directors of CYTOVAC A/S.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.